Status:
TERMINATED
Role of Children in Transmission of COVID-19 to Immunocompromised Patients
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Immunosuppression
Eligibility:
All Genders
Brief Summary
This is a study of immunosuppressed individuals living in households with and without children to assess the role of household contact with children in the transmission of SARSCoV-2 to immunocompromis...
Detailed Description
This is a prospective, longitudinal cohort study of immunosuppressed patients living in households with and without children to assess the role of household contact with children in the transmission o...
Eligibility Criteria
Inclusion
- Immunocompromised patient followed at UCLA Health
- Immunocompromised patient \>1 day old to \<60 years of age
- Patient with a diagnosis of breast, lung, or colorectal cancers, lymphoma, acute/chronic leukemia, multiple myeloma, or other solid tumors and are receiving chemotherapy
- Patients who have received a hematopoietic stem cell transplantation within the last year
- Patients who have received a solid organ transplantation within the last year
Exclusion
- Immunocompromised patients with positive SARS-CoV-2 test prior to study enrollment
Key Trial Info
Start Date :
May 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2023
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT04407546
Start Date
May 27 2020
End Date
March 13 2023
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California at Los Angeles
Los Angeles, California, United States, 90095